DongKook Life Science KRX:303810KOSDAQ

동국생명과학 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days31
DART filings, 7 days2
Articles tracked34since Sep 11

In Q2 2026, DongKook Life Science reported revenue of ₩24.3bn, down 30.5% year on year, and operating profit of ₩22m. DongKook Life Science (동국생명과학) appeared in 31 Korean news articles and 2 DART filings over the past seven days. Coverage peaked on Oct 26 with 28 articles. The most common catalyst was policy & overseas (1). It was most often mentioned alongside 글로벌테크놀로지, Shaperon and LigaChem Biosciences.

DongKook Life Science quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩24.3bn-30.5%₩22m
margin 0.1%
−₩888m
Q1 2026₩33.1bn-5.6%₩3.4bn
margin 10.4%
₩2.3bn
Q4 2025 derived₩31.0bn-2.6%₩2.5bn
margin 7.9%
₩1.1bn
Q3 2025₩29.4bn-9.2%₩4.3bn
margin 14.5%
₩2.4bn
Q2 2025₩34.9bn+2.5%₩3.2bn
margin 9.2%
₩2.9bn
Q1 2025₩35.1bn+4.4%₩3.1bn
margin 8.9%
₩2.2bn
Q4 2024 derived₩31.8bn–₩2.4bn
margin 7.7%
−₩784m
Q3 2024₩32.4bn–₩3.5bn
margin 10.8%
₩3.7bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

DongKook Life Science top stories 2 weeks, by number of outlets

  1. 1
    동국생명과학, '디케이루오닉스'로 사명 변경 추진
    8 outlets · 9 articlesFirst report Oct 26 11:58 메디파나뉴스
  2. 2
  3. 3
  4. 4
    동국생명과학, ‘DK루오닉스’로 사명 변경 추진…신약·CMO 사업 확대
    1 outlets · 2 articlesFirst report Oct 26 13:42 이데일리
  5. 5
    동국생명과학, 'DK루오닉스'로 이름 바꾼다
    1 outlets · 1 articlesFirst report Oct 26 16:21 전자신문
  6. 6
    동국생명과학도 이름 바꾼다, DK루오닉스로
    1 outlets · 1 articlesFirst report Oct 26 17:23 히트뉴스

Latest DongKook Life Science news Korean headlines